120 related articles for article (PubMed ID: 9863473)
21. Pregnancy outcome after first trimester exposure to corticosteroids: a prospective controlled study.
Gur C; Diav-Citrin O; Shechtman S; Arnon J; Ornoy A
Reprod Toxicol; 2004; 18(1):93-101. PubMed ID: 15013068
[TBL] [Abstract][Full Text] [Related]
22. The safety of omeprazole during pregnancy: a multicenter prospective controlled study.
Lalkin A; Loebstein R; Addis A; Ramezani-Namin F; Mastroiacovo P; Mazzone T; Vial T; Bonati M; Koren G
Am J Obstet Gynecol; 1998 Sep; 179(3 Pt 1):727-30. PubMed ID: 9757979
[TBL] [Abstract][Full Text] [Related]
23. Massive pericardial effusion in a child following the administration of mesalamine.
Kaiser GC; Milov DE; Erhart NA; Bailey DJ
J Pediatr Gastroenterol Nutr; 1997 Oct; 25(4):435-8. PubMed ID: 9327378
[No Abstract] [Full Text] [Related]
24. Drug-induced fibrosing colonopathy in inflammatory bowel disease after 5-ASA?
Allgayer H; Böhne P; Kruis W
Dig Dis Sci; 1999 Aug; 44(8):1600. PubMed ID: 10492139
[No Abstract] [Full Text] [Related]
25. [Agranulocytosis and transitory immune deficiency after fetal exposure to azathioprine and mesalazine].
Cissoko H; Jonville-Béra AP; Lenain H; Rivière MF; Saugier J; Casanova JL; Autret-Leca E
Arch Pediatr; 1999 Oct; 6(10):1136-7. PubMed ID: 10544800
[No Abstract] [Full Text] [Related]
26. Mesalamine-induced granulomatous hepatitis.
Braun M; Fraser GM; Kunin M; Salamon F; Tur-Kaspa R
Am J Gastroenterol; 1999 Jul; 94(7):1973-4. PubMed ID: 10406274
[TBL] [Abstract][Full Text] [Related]
27. Association of maternal lithium exposure and premature delivery.
Troyer WA; Pereira GR; Lannon RA; Belik J; Yoder MC
J Perinatol; 1993; 13(2):123-7. PubMed ID: 8515304
[TBL] [Abstract][Full Text] [Related]
28. The Effects of Active IBD During Pregnancy in the Era of Novel IBD Therapies.
de Lima-Karagiannis A; Zelinkova-Detkova Z; van der Woude CJ
Am J Gastroenterol; 2016 Sep; 111(9):1305-12. PubMed ID: 27349339
[TBL] [Abstract][Full Text] [Related]
29. Cocaine abuse during pregnancy: maternal and fetal implications.
Little BB; Snell LM; Klein VR; Gilstrap LC
Obstet Gynecol; 1989 Feb; 73(2):157-60. PubMed ID: 2911419
[TBL] [Abstract][Full Text] [Related]
30. Risk of adverse birth outcome and miscarriage in pregnant users of non-steroidal anti-inflammatory drugs: population based observational study and case-control study.
Nielsen GL; Sørensen HT; Larsen H; Pedersen L
BMJ; 2001 Feb; 322(7281):266-70. PubMed ID: 11157526
[TBL] [Abstract][Full Text] [Related]
31. How important is mesalamine in the maintenance of steroid-refractory colitis?
Actis GC; Marzano A; Pellicano R; Rizzetto M
Inflamm Bowel Dis; 2008 Jul; 14(7):1026. PubMed ID: 18338772
[No Abstract] [Full Text] [Related]
32. Safety of topical 5-aminosalicylic acid in pregnancy.
Bell CM; Habal FM
Am J Gastroenterol; 1997 Dec; 92(12):2201-2. PubMed ID: 9399752
[TBL] [Abstract][Full Text] [Related]
33. Once-daily mesalamine (Lialda) for ulcerative colitis.
Med Lett Drugs Ther; 2007 Mar; 49(1257):25-6. PubMed ID: 17375030
[No Abstract] [Full Text] [Related]
34. Therapeutic drug use in women with Crohn's disease and birth outcomes: a Danish nationwide cohort study.
Nørgård B; Pedersen L; Christensen LA; Sørensen HT
Am J Gastroenterol; 2007 Jul; 102(7):1406-13. PubMed ID: 17437503
[TBL] [Abstract][Full Text] [Related]
35. Mesalamine (5-aminosalicylic acid) therapy well tolerated in a patient with aspirin hypersensitivity and ulcerative colitis.
Murphy SJ; Mayer L; Abreu MT
J Clin Gastroenterol; 2011 Jan; 45(1):83-4. PubMed ID: 20535023
[No Abstract] [Full Text] [Related]
36. Prescribing in pregnancy. Corticosteroids.
Sidhu RK; Hawkins DF
Clin Obstet Gynaecol; 1981 Aug; 8(2):383-404. PubMed ID: 6271447
[No Abstract] [Full Text] [Related]
37. Encapsulated mesalamine granules (Apriso) for ulcerative colitis.
Med Lett Drugs Ther; 2009 May; 51(1312):38-9. PubMed ID: 19448588
[TBL] [Abstract][Full Text] [Related]
38. Which 5-ASA?
Mansfield JC
Gut; 2003 May; 52(5):771. PubMed ID: 12692073
[No Abstract] [Full Text] [Related]
39. Follow-up study of intrauterine growth of transplacental Yu-Cheng babies in Taiwan.
Yen YY; Lan SJ; Yang CY; Wang HH; Chen CN; Hsieh CC
Bull Environ Contam Toxicol; 1994 Nov; 53(5):633-41. PubMed ID: 7833597
[No Abstract] [Full Text] [Related]
40. Mesalazine-induced psoriasis in patients with inflammatory bowel diseases.
Di Cesare A; Fidanza R; Riitano A; Fargnoli MC; Peris K
Eur J Dermatol; 2011; 21(5):784-5. PubMed ID: 21697068
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
